Brazilian Journal of Pain
https://brjp.org.br/article/doi/10.5935/2595-0118.20210061
Brazilian Journal of Pain
Artigo de Revisão

The expression of the nitric oxide synthase enzyme in periodontal disease and orofacial pain: systematic review

A expressão da enzima óxido nítrico sintase na doença periodontal e na dor orofacial: revisão sistemática

Daniel Jackson Gonçalves Carvalho; Isis Pereira Cardoso; Iasminy Soares Oliveira; Maria das Graças Afonso Miranda Chaves; Gisele Maria Campos Fabri

http://dx.doi.org/10.5935/2595-0118.20210061 BrJP, vol.4, n4, p.362-368, 2021
PDF English
PDF Português
SciELO
Downloads: 0
Views: 434

Abstract

BACKGROUND AND OBJECTIVES: The literature suggests that the enzyme nitric oxide synthase (NOS) plays an important role in both periodontal disease (PD) and orofacial pain (OP), although few studies associate these two conditions simultaneously. The objective of this study was to evaluate the expression of the NOS enzyme in PD and OP, in comparison to those patients who did not present PD and/or OP.

CONTENTS: Seven electronic databases (Pubmed, Web of science, Scopus, Cochrane Library, BBO, LILACS, Clinical trial) were used to identify the potentially relevant studies published until April 2021. The research resulted in 1,960 studies, of which 11 were selected to be critically evaluated. Two independent reviewers selected titles and abstracts using the criteria defined in the PECO question (Population, Exposure, Comparison, Outcome). The methodological evaluation of the selected studies was carried out according to the Effective Public Health Practice Project (EPHPP).

CONCLUSION: Scientific evidence demonstrated that NOS may play a key role in the pathogenesis of PD and OP, since its expression is increased in patients with these conditions. However, genetic studies on endothelial nitric oxide synthase (eNOS) gene mutations in patients with migraine and cluster headache did not indicate the expected susceptibility to pain. In addition, studies on the association of NOS expression in PD and OP, occurring simultaneously, are scarce. This review may support future research on NOS in two very common correlated diseases such as PD and OP.

Keywords

Orofacial pain, Nitric oxide, Nitric oxide synthase, Periodontal diseases

Resumo

JUSTIFICATIVA E OBJETIVOS: A literatura sugere que a enzima óxido nítrico sintase (NOS) desempenha um papel importante tanto na doença periodontal (DP) quanto na dor orofacial (DOF), embora poucos estudos associem estas duas condições simultaneamente. O objetivo deste estudo foi analisar a expressão da NOS em pacientes com DP e DOF em comparação a controles sem estas condições.

CONTEÚDO: Foram consultadas as bases de dados eletrônicas (Pubmed, Web of Science, Scopus, Cochrane Library, BBO, Lilacs e Clinical Trial) para identificar os estudos potencialmente relevantes publicados até abril de 2021. As pesquisas resultaram em 1.960 estudos, dos quais 11 foram selecionados para serem avaliados criticamente. Os critérios definidos na questão PECO (População, Exposição, Comparação e Desfecho) foram usados para selecionar títulos e resumos por dois revisores independentes. A avaliação metodológica dos estudos selecionados foi realizada de acordo com a ferramenta Effective Public Health Practice Project (EPHPP).

CONCLUSÃO: As evidências científicas demonstraram que a NOS desempenha um importante papel na patogênese da DP e da DOF, já que sua expressão está aumentada em pacientes com estas condições. Porém, estudos genéticos sobre mutações dos genes do óxido nítrico sintase endotelial (eNOS) em pacientes com migrânea e cefaleia em salvas não evidenciaram a esperada suscetibilidade a dor. Além disso, estudos sobre a associação da expressão da NOS na DP e na DOF, ocorrendo simultaneamente, são escassos. Este estudo pode subsidiar futuras pesquisas sobre NOS na correlação de duas doenças muito frequentes como a DP e a DOF.

Palavras-chave

Doença periodontal, Dor orofacial, Óxido nítrico, Óxido nítrico sintase

Referências

Albandar MJ, Rams ET. Risk factors for periodontitis in children and young persons. Periodontology. 2000;2002(29):207-22.

Kinane DF, Stathopoulos PG, Papapanou PN. Periodontal diseases. Nat Rev Dis Primers. 2017;3:17038.

Cestari JA, Fabri GM, Kalil J, Nitrini R, Jacob-Filho W, de Siqueira JT. Oral infections and cytokine levels in patients with Alzheimer’s disease and mild cognitive impairment compared with controls. J Alzheimers Dis. 2016;52(4):1479-85.

Fabri GM, Pereira RM, Savioli C, Saad CG, de Moraes JC, Siqueira JT. Periodontitis response to anti-TNF therapy in ankylosing spondylitis. J Clin Rheumatol. 2015;21(7):341-5.

Fabri GM, Siqueira SR, Simione C, Nasri C, Teixeira MJ, Siqueira JTT. Refractory craniofacial pain: is there a role of periodontal disease as a comorbidity?. Arq Neuropsiquiatr. 2009;67(2B):4749.

Ozmeric N, Elgu NS, Uraz A. Salivary arginase in patients with adult periodontitis. Clin Oral Invest. 2000:21-4.

Kendall HK, Haase HR, Li H, Xiao Y, Bartold PM. Nitric oxide synthase type-II is synthesized by human gingival tissue and cultured human gingival fibroblasts. J Periodont Res. 2000:194-200.

Teixeira MJ, Marconi RM, Rocha RO, Figueiró JB. Epidemiologia clínica da dor. Rev Med. 1999:36-54.

J Int Headache. 2004.

Siqueira JTT, Teixeira MJ. Dor orofacial: diagnóstico, terapêutica e qualidade de vida. 2001:656p.

Anbar M, Gratt BM. Role of nitric oxide in the physiopathology of pain. J. Pain Symptom Manage. 1997;14(4):225-54.

Ricciardolo FL, Sterk PJ, Gaston B, Folkerts L. Nitric oxide in health and disease of the respiratory system. Physiol Rev. 2004;84(3):731-65.

Akerman S, Williamson DJ, Kaube H, Goadsby PJ. Nitric oxide synthase inhibitors can antagonize neurogenic, and calcitonin gene-related peptide induced dilation of dural meningeal vessels. Br J Pharmacol. 2002:62-8.

Sjöstrand C, Modin H, Masterman T, Ekbom K, Waldenlind E, Hillert J. Analysis of nitric oxide synthase genes in cluster headache. Cephalalgia. 2002;22(9):758-64.

Armijo OS, Stiles CR, Hagen NA, Biondo PD, Cummings GC. Assessment of study quality for systematic reviews: a comparison of the Cochrane Collaboration Risk of Bias Tool and the Effective Public Health Practice Project Quality Assessment tool: methodological research. J Eval Clin Pract. 2012;18(1):12-8.

Fabri GMC, Sannomiya P, Prado CM, Leick-Maldonado EA, De Siqueira SRDT, Tibério IFC. The expression of nitric oxide in the gingival tissue in subjects with periodontitis and chronic pain. Int J Odontostomat. 2014;8(2):279-87.

Gruber HJ, Bernecker C, Lechner A, Weiss S, Wallner BA, Meinitzer A. Increased nitric oxide stress is associated with migraine. Cephalalgia. 2010;30(4):486-92.

Toriello M, Oterino A, Pascual J, Castillo J, Colás R, Alonso-Arranz A. Lack of Association of endothelial nitric oxide synthase polymorphisms and migraine. Headache. 2008;48(7):1115-9.

Batista AC, Silva TA, Chun JH, Lara VS. Nitric oxide synthesis and severity of human periodontal disease. Oral Dis. 2002;8(5):254-60.

Shibata K, Warbington ML, Gordon BJ, Kurihara H, Van Dyke TE. Nitric oxide synthase activity in neutrophils from patients with localized aggresive peridontitis. J Periodontol. 2001;72(8):1052-8.

Lappin DF, Kjeldsen M, Sander L, Kinane DF. Inducible nitric oxide synthase expression in periodontitis. J Periodont Res. 2000;35(6):369-73.

Van der Schueren BJ, Verbrugge FH, Verbesselt R, Van Hecken U, Depré M, de Hoon JN. No arguments for increased endothelial nitric oxide synthase activity in migraine based on peripheral biomarkers. Cephalalgia. 2010;30(11):1354-65.

Güllu C, Ozmeric N, Tokman B, Elgun S, Balos K. Effectiveness of scaling and root planing versus modified Widman flap on nitric oxide synthase and arginase activity in patients with chronic periodontitis. J Periodont Res. 2005;40(2):168-75.

Takahashi T, Homma H, Nagai H, Seki H, Kondoh T, Yamazaki Y. Specific expression of inducible nitric oxide synthase in the synovium of the diseased temporomandibular joint. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2003;95(2):174-81.

Aguilar FME, Casas BA, Rus A, Haro RMTP, Martos JMM, Molina F. Among nitric oxide and enkephalinases with fibromyalgia symptoms. Nurs Res. 2020;70(2):11-20.

Baad-Hansen L, Benoliel R. Neuropathic orofacial pain: facts and fiction. Cephalalgia. 2017;37(7):670-9.

Woldeamanuel YW, Cowan RP. Migraine affects 1 in 10 people worldwide featuring recent rise: a systematic review and meta-analysis of community-based studies involving 6 million participants. J Neurol Sci. 2017;372:307-15.

Kassebaum NJ, Smith AGC, Bernabé E, Fleming TD, Reynolds AE, Vos T. Global, regional and national prevalence, incidence, and disability-adjusted life years for oral conditions for 195 countries, 1990-2015: a systematic analysis for the Global Burden of Diseases, Injuries and Risk Factors. J Dent Res. 2017;96(4):380-7.

Haviv Y, Zini A, Etzioni Y, Klitinich V, Dobriyan A, Sharavet Y. The impact of chronic orofacial pain on daily life: the vulnerable patient and disruptive pain. Oral Surg Oral Med Oral Pathol Oral Radiol. 2017;123(1):58-66.

Nazir MA. Prevalence of periodontal disease, its association with systemic diseases and prevention. Int J Health Sci (Qassim). 2017;11(2):72-80.

de-Pedro-Herráez M, Mesa Jiménez J, Fernández-de-Las-Penãs C, de-la-Hos-Aizpurua JL. Myogenic temporomandibular disorders: Clinical systemic comorbidities in a female population sample. Med Oral Patol Oral Cir Bucal. 2016;21(6):e784-92.

Lohinai Z, Benedek P, Fehér E, Györfi A, Rosivall L, Fazekas A. Protective effects of mercaptoethylguanidine, a selective inhibitor of inducible nitric oxide synthase, in ligature-induced periodontitis in the rat. Br J Pharmacol. 1998;123(3):353-60.

Hirose M, Ishihara K, Saito A, Nakagawa T, Yamada S, Okuda K. Expression of cytokines and inducible nitric oxide synthase in inflamed gingival tissue. J Periodontol. 2001;72(5):590-7.

Daghigh F, Borghaei RC, Thornton RD, Bee JH. Human gingival fibroblasts produce nitric oxide in response to proinflammatory cytokines. J Periodontol. 2002;73(4):392-400.

Roberts FA, McCaffery KA, Michalak SM. Profile of cytokine mRNA expression in chronic adult periodontitis. J Dent Res. 1997;76(12):1833-44.

Spiller F, Oliveira Formiga R, Fernandes da Silva Coimbra J, Alves-Filho JC, Cunha TM. Targeting nitric oxide as a key modulator of sepsis, arthritis and pain. Nitric Oxide. 2019;1(89):32-40.

Ashina M, Lassen LH, Bendtsen L, Jensen R, Olesen J. Effect of inhibition of nitric oxide synthase on chronic tension-type headache: a randomised crossover trial. Lancet. 1999;353(9149):287-9.

Cutrer FM. Pathophysiology of migraine. Semin Neurol. 2006;26(2):171-80.

Neeb L, Reuter U. Nitric oxide in migraine. CNS Neurol Disord Drug Targets. 2007;6(4):258-64.

Bellamy J, Bowen EJ, Russo AF, Durham PL. Nitric oxide regulation of calcitonin gene-related peptide gene expression in trigeminal ganglia neurons. Eur J Neurosci. 2006;23(8):2057-66.

Veldman BA, Spiering W, Doevendans PA, Vervoort G, Kroon AA, de Leeuw PW. The Glu298Asp polymorphism of the NOS3 gene as a determinant of the baseline production of nitric oxide. J Hipertens. 2002;20(10):2023-7.

Yoshihiro M, Yoshihiko S, Masafumi N, Yukio S, Toshihiro Y, Yoshimura M. T-786C mutation in the 5 -flanking regions of the endothelial nitric oxide synthase gene is associated with coronary spasm. Circulation. 1999;99:2864-70.

Taffi R, Vignini A, Lanciotti C, Luconi R, Nanetti L, Mazzanti L. Platelet membrane fluidity and peroxynitrite levels in migraine patients during headache-free periods. Cephalalgia. 2005;25(5):353-8.

Pradhan AA, Bertels Z, Akerman S. Targeted nitric oxide synthase inhibitors for migraine. Neurotherapeutics. 2018;15(2):391-401.

Myles PS, Leslie K, Chan MT, Forbes A, Paech MJ, Peyton P. Avoidance of nitrous oxide for patients undergoing major surgery: a randomized controlled trial. Anesthesiology. 2007;107(2):221-31.

Böger RH, Bode-Böger SM, Thiele W, Junker W, Alexander K, Frölich JC. Biochemical evidence for impaired nitric oxide synthesis in patients with peripheral arterial occlusive disease. Circulation. 1997;95(8):2068-74.

Michel T, Feron O. Nitric oxide synthases: which, where, how, and why?. J Clin Invest. 1997;100(9):2146-52.

Takahashi T, Kondoh T, Fukuda H, Yamazaki Y, Toyosaki T, Suzuki R. Proinflammatory cytokines detectable in synovial fluids from patients with temporomandibular disorders. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1998;85(2):135-41.

Palmer RM, Ferrige AR, Moncada S. Nitric oxide accounts for the biological activity of endothelium-derived relaxing factor. Nature. 1987;327(6122):524-6.

Leibovich SJ, Polverini PJ, Fong TW, Harlow LA, Koch AE. Production of angiogenic activity by human monocytes requires an L-arginine/nitric oxide-synthase-dependent effector mechanism. Proc Natl Acad Sci USA. 1994;91(10):4190-4.

Amin AR, Abramson SB. The role of nitric oxide in articular cartilage breakdown in osteoarthritis. Curr Opin Rheumatol. 1998;10(3):263-8.

Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BA. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci USA. 1990;87(4):1620-4.

Gomes FIF, Cunha FQ, Cunha TM. Peripheral nitric oxide signaling directly blocks inflammatory pain. Biochem Pharmacol. 2020;176:113862.

Submetido em:
20/02/2021

Aceito em:
03/05/2021

61e7194da9539556b91b5a03 brjp Articles
2595-3192 (Eletrônico) 2595-0118 (Impresso)
BrJP ©2024 Todos os direitos reservados.

BrJP

Share this page
Page Sections